BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 16788756)

  • 1. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
    Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
    Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
    Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma.
    Tsunedomi R; Iizuka N; Hamamoto Y; Uchimura S; Miyamoto T; Tamesa T; Okada T; Takemoto N; Takashima M; Sakamoto K; Hamada K; Yamada-Okabe H; Oka M
    Int J Oncol; 2005 Sep; 27(3):661-7. PubMed ID: 16077914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
    Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.
    Woo HG; Park ES; Cheon JH; Kim JH; Lee JS; Park BJ; Kim W; Park SC; Chung YJ; Kim BG; Yoon JH; Lee HS; Kim CY; Yi NJ; Suh KS; Lee KU; Chu IS; Roskams T; Thorgeirsson SS; Kim YJ
    Clin Cancer Res; 2008 Apr; 14(7):2056-64. PubMed ID: 18381945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of differentially expressed genes in hepatocellular carcinoma with hepatitis C virus by suppression subtractive hybridization.
    Kotaka M; Chen GG; Lai PB; Lau WY; Chan PK; Leung TW; Li AK
    Oncol Res; 2002; 13(3):161-7. PubMed ID: 12549625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.
    Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Tangoku A; Hamada K; Nakayama H; Miyamoto T; Uchimura S; Hamamoto Y
    Cancer Res; 2002 Jul; 62(14):3939-44. PubMed ID: 12124323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis?
    Nakata T; Seki N; Miwa S; Kobayashi A; Soeda J; Nimura Y; Kawasaki S; Miyagawa S
    Hepatogastroenterology; 2008; 55(84):865-72. PubMed ID: 18705285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-based molecular profiling of hepatitis C virus-related hepatocellular carcinoma.
    Takemoto N; Iizuka N; Yamada-Okabe H; Hamada K; Tamesa T; Okada T; Hashimoto K; Sakamoto K; Takashima M; Miyamoto T; Uchimura S; Hamamoto Y; Oka M
    Int J Oncol; 2005 Mar; 26(3):673-8. PubMed ID: 15703822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.
    Mas VR; Fisher RA; Archer KJ; Yanek KC; Williams B; Dumur CI; Maluf DG
    Transplantation; 2007 Apr; 83(7):973-81. PubMed ID: 17460570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays.
    Shirota Y; Kaneko S; Honda M; Kawai HF; Kobayashi K
    Hepatology; 2001 Apr; 33(4):832-40. PubMed ID: 11283847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile.
    Tsunedomi R; Iizuka N; Yamada-Okabe H; Tamesa T; Okada T; Sakamoto K; Takashima M; Hamaguchi T; Miyamoto T; Uchimura S; Hamamoto Y; Yamada M; Oka M
    Int J Oncol; 2006 Dec; 29(6):1445-51. PubMed ID: 17088983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.
    Iizuka N; Oka M; Yamada-Okabe H; Hamada K; Nakayama H; Mori N; Tamesa T; Okada T; Takemoto N; Matoba K; Takashima M; Sakamoto K; Tangoku A; Miyamoto T; Uchimura S; Hamamoto Y
    Int J Oncol; 2004 Mar; 24(3):565-74. PubMed ID: 14767541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
    Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of potential genomic portraits associated with intrahepatic recurrence in human hepatocellular carcinoma.
    Kittaka N; Takemasa I; Seno S; Takeda Y; Kobayashi S; Marubashi S; Dono K; Umeshita K; Nagano H; Matsuda H; Monden M; Mori M; Doki Y
    Ann Surg Oncol; 2010 Dec; 17(12):3145-54. PubMed ID: 20625842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.